Another reason behind the soured sentiments has been the extended sell-off in the chip / memory / AI-linked stocks. From its intraday high of June 3, the S&P 500 is already down over 5%. For the Nasdaq, which made a…
In its earnings statement, Oracle said that it now foresees raising $40 billion through debt and equity financing this year, double of the $20 billion it had earlier projected.
Spot bullion was down more than 3% after the latest comments by Trump, who has vacillated from threats of intensified attacks to touting that a deal is within reach since almost the start of the conflict.
The tech giant agreed to a $17.5 billion delayed-draw term loan with banks including Citigroup Inc., according to a filing on Wednesday (June 10).
Super Micro is tapping capital markets to finance a growing AI server business backed by nearly $39 billion in orders. While analysts see the fundraising supporting long-term revenue growth, investors reacted negatively to the prospect of significant shareholder dilution.
Pimco, which manages $2.3 trillion in assets, said the AI buildout could widen the range of economic outcomes over the next five years while leaving weaker and more heavily leveraged borrowers exposed.
President Donald Trump’s unexpected endorsement of Citigroup CEO Jane Fraser put the bank’s dealmaking business in the spotlight, even as industry league tables showed the lender trailing several rivals in overall M&A advisory rankings. The remarks underscore the growing attention…
UltraTech Cement Ltd has entered into an Energy Supply Agreement and a Share Subscription and Shareholders Agreement to acquire a 13.99% equity stake in FPEL Services Pvt. Ltd., a company engaged in the generation and transmission of renewable energy through…
Rajesh Exports chairman Rajesh Mehta said SEBI’s ₹15.15 lakh crore revenue inflation concern stems from a misunderstanding of Valcambi’s financials, arguing that the regulator treated EBITDA as revenue while several other queries remain under examination.
Shares of IOL Chemicals and Pharmaceuticals Ltd ended at ₹129.95, down by ₹2.95, or 2.22%, on the BSE.